Related Experiment Video
Updated: Aug 29, 2025

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
Published on: February 10, 2023
Deep Venous Thrombosis
1The Ottawa Hospital, Ottawa, Ontario, Canada.
Insights
Venous thromboembolism (VTE), a common cardiovascular issue, can often be prevented with prophylaxis. Direct oral anticoagulants offer effective and safer treatment options for VTE management.
Area of Science:
- Cardiovascular Medicine
- Hematology
Background:
- Venous thromboembolism (VTE) is a significant global health concern, ranking as the third most common cardiovascular disorder.
- VTE encompasses deep venous thrombosis (DVT) and pulmonary embolism, impacting up to 5% of the population.
- A substantial portion of VTE cases are linked to transient risk factors, highlighting potential for preventive strategies.
Purpose of the Study:
- To review the epidemiology, risk factors, and management of venous thromboembolism.
- To compare the safety and efficacy of direct oral anticoagulants (DOACs) with traditional anticoagulants.
- To discuss the long-term implications of VTE, including postthrombotic syndrome.
Main Methods:
- Literature review of epidemiological data on VTE prevalence and risk factors.
- Comparative analysis of clinical trial data for DOACs versus vitamin K antagonists.
- Synthesis of evidence regarding the prevention and management of VTE and its complications.
Main Results:
- Half of VTE events are associated with transient risk factors, suggesting a role for prophylaxis.
- Direct oral anticoagulants demonstrate comparable efficacy to vitamin K antagonists with a reduced risk of bleeding.
- Postthrombotic syndrome affects a significant percentage (25%-40%) of DVT patients, impacting quality of life.
Conclusions:
- VTE is a prevalent cardiovascular condition with significant morbidity.
- DOACs represent an effective and safer alternative for anticoagulation therapy in VTE.
- Effective VTE management and prophylaxis are crucial to mitigate long-term complications like postthrombotic syndrome.
Abstract:
Venous thromboembolism (VTE) is the third most common cardiovascular disorder, affecting up to 5% of the population. VTE commonly manifests as lower-extremity deep venous thrombosis (DVT) or pulmonary embolism. Half of these events are associated with a transient risk factor and may be preventable with prophylaxis. Direct oral anticoagulants are effective and safe and carry a lower risk for bleeding than vitamin K antagonists. Many patients with VTE will have a chronic disease requiring long-term anticoagulation. Postthrombotic syndrome affects 25% to 40% of patients with DVT and significantly impacts function and quality of life.
Related Concept Videos
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis IV: Nursing Management
Venous Return
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
Pulmonary Embolism I: Introduction

